Oncimmune Holdings Plc (ONC.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 05-2018 | 05-2017 | 05-2016 | 05-2015 | 05-2014 | |
| Sales | 240 | 215 | 430 | 1,345 | 1,057 |
| Cost of Goods | 917 | 532 | 147 | 3 | 141 |
| Gross Profit | -677 | -317 | 283 | 1,342 | 916 |
| Operating Expenses | 5,697 | 4,956 | 5,997 | 2,724 | 3,671 |
| Operating Income | -6,374 | -5,273 | -5,714 | -1,382 | -2,755 |
| Interest Expense | 16 | 69 | 737 | 646 | 350 |
| Other Income | 48 | 26 | -2,557 | 15 | 1,512 |
| Pre-tax Income | -6,342 | -5,316 | -9,008 | -2,013 | -1,593 |
| Income Tax | 0 | -293 | -566 | 0 | -181 |
| Net Income Continuous | -6,342 | -5,023 | -8,442 | -2,013 | -1,412 |
| Net Income | $-6,342 | $-5,023 | $-8,442 | $-2,013 | $-1,412 |
| EPS Basic Total Ops | -0.11 | -0.10 | -0.24 | -0.04 | -0.03 |
| EPS Basic Continuous Ops | -0.11 | -0.10 | -0.24 | -0.04 | -0.03 |
| EPS Diluted Total Ops | -0.11 | -0.10 | -0.24 | -0.04 | -0.03 |
| EPS Diluted Continuous Ops | -0.11 | -0.10 | -0.24 | -0.04 | -0.03 |
| EBITDA(a) | $-6,146 | $-5,156 | $-8,193 | $-1,326 | $-1,202 |